Exsure
PrivateLast Round
Seed
Jan 22, 2025
Total Funding Raised
$349,000
Company Overview
Exsure is a biotechnology company that develops an exosome-based drug delivery platform for targeted cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exsure Comparables
Compare Exsure with similar companies based on industry and business-model similarity.
Exsure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 22, 2025 |
Key People
Founding team and executive leadership
Exsure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IIT Mandi Catalyst | Seed |
| Unicorn India Ventures | Seed |
| Venture Center | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 9, 2025
Monthly visitors increased 79% MoM.
- Nov 8, 2025
Monthly visitors increased 80% MoM.
Exsure Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Exsure's valuation, stock price, and market status.